Fusafungine

Revision as of 16:33, 13 April 2015 by Turky Alkathery (talk | contribs)
Jump to navigation Jump to search
Fusafungine
Clinical data
SynonymsFusafungin
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
DrugBank
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC29H51N2O8
Molar mass555.72 g/mol[1]
 ☒N☑Y (what is this?)  (verify)

Fusafungine (INN), also known as fusafungin, is an active agent used in antibiotics for treatment of nasal and throat infection. It also possesses anti-inflammatory properties. Fusafungine is a mixture of enniatin cyclohexadepsipeptides made up of alternating D-α-hydroxyvaleric acid and L-N-methylamino acid residues,[2] produced by the ascomycete Fusarium lateritium, and marketed by Servier under the trade names Locabiotal, Bioparox, and Locabiosol.

According to a pooled analysis study done in the UK for the efficacy of fusafungine in rhinopharingitis, it was found that the proportion of patients who showed an improvement in symptoms from Day 0 to Day 4 of infection was 61.5% with fusafungine vs. 46.8% when compared to a placebo.[3]

References

  1. Fusafungine at MeSH
  2. Daniel Levy, Aline Bluzat, Michel Seigneuret and Jean-Louis Rigaud (1995). "Alkali cation transport through liposomes by the antimicrobial fusafungine and its constitutive enniatins". Biochemical Pharmacology. 50 (12 22): 2105–2107. doi:10.1016/0006-2952(95)02045-4. PMID 8849339.
  3. PMID 15626253 (PMID 15626253)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

Template:Throat preparations


Template:Antibiotic-stub Template:Respiratory-system-drug-stub